ArticleTranslational lung cancer research2021

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy.

Xin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.